pravind personal page - To The Moon

pravind

pravind

No personal profile

4Follow

26Followers

0Topic

0Badge

01-13

$Sentage Holdings Inc(SNTG)$

2023-04-11

Bull markeT let's go

2022-09-01

$Tiger Brokers(TIGR)$

2022-08-17

Is this good for us?

Endo Files for Bankruptcy As U.S. Opioid Litigation Drags

2022-07-03

$Evofem Biosciences Inc.(EVFM)$🚀

2022-06-24

$MULN!

Russell Rebalance May See Highest-Volume Trading Session of the Year

2022-06-09

$Praxis Precision Medicines, Inc.(PRAX)$Cmon!

2022-06-06

$SAVERONE 2014 LTD(SVRE)$Saver everyone

2022-06-01

$NASDAQ(.IXIC)$Stupid nasdaq

2022-05-31

$NASDAQ(.IXIC)$Suck beans

2022-05-17

I feel that whole Market is rigged.Prior to Biden's entry to office, take a look at how Tech stocks Emerged. Now Almost Every stock is undervalued. Worse of All, people do not Hold And grab profits and sell within 1-2 days

2022-04-23

$Mullen Automotive(MULN)$is the future

2022-01-26

Oh

Wall Street Ends down as Markets Whipsaw Ahead of Fed Meeting

2022-01-13

Wow

TSMC Announced Consolidated Revenue of NT$438.19 Billion, Gross Margin for the Fourth Quarter was 52.7%

2021-12-20

Oh

EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022

2021-09-23

$Clover Health Corp(CLOV)$??

2021-09-13

Yo

IPO Update: Definitive Healthcare Aims For $350 Million IPO

2021-08-28

$Lucid Group Inc(LCID)$Below 20 is a buy ✌?

2021-08-25

$Beyondspring Inc(BYSI)$PT $95/ $100

2021-08-18

$Virpax Pharmaceuticals, Inc.(VRPX)$Take a chill pill at this stock.. just know when to run ??

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3573383772698946","uuid":"3573383772698946","gmtCreate":1610289749407,"gmtModify":1732540053600,"name":"pravind","pinyin":"pravind","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":26,"headSize":4,"tweetSize":181,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":262399810961624,"gmtCreate":1705096485041,"gmtModify":1705096487263,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SNTG\">$Sentage Holdings Inc(SNTG)$</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/SNTG\">$Sentage Holdings Inc(SNTG)$</a>&nbsp;","text":"$Sentage Holdings Inc(SNTG)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/262399810961624","isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9942845912,"gmtCreate":1681193061237,"gmtModify":1681193064684,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Bull markeT let's go&nbsp;","listText":"Bull markeT let's go&nbsp;","text":"Bull markeT let's go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9942845912","isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9939911519,"gmtCreate":1662040755233,"gmtModify":1676536704532,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><v-v data-views=\"1\"></v-v>","text":"$Tiger Brokers(TIGR)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939911519","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9993422885,"gmtCreate":1660718897649,"gmtModify":1676536386444,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Is this good for us?","listText":"Is this good for us?","text":"Is this good for us?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9993422885","repostId":"1128839302","repostType":2,"repost":{"id":"1128839302","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1660715477,"share":"https://ttm.financial/m/news/1128839302?lang=&edition=fundamental","pubTime":"2022-08-17 13:51","market":"us","language":"en","title":"Endo Files for Bankruptcy As U.S. Opioid Litigation Drags","url":"https://stock-news.laohu8.com/highlight/detail?id=1128839302","media":"Reuters","summary":"Aug 16 (Reuters) - Endo International Plcfiled for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over i","content":"<html><head></head><body><p>Aug 16 (Reuters) - Endo International Plc filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over its alleged role in the country&#39;s opioid epidemic.</p><p>The pharmaceutical company is the latest to file for Chapter 11 to address opioid claims. Purdue Pharma, the maker of OxyContin, filed in September 2019, while Mallinckrodt Plc, a generic opioid manufacturer, recently emerged from bankruptcy.</p><p>&#34;By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the company has been defending at an unsustainable cost, we will be able to move forward...,&#34; Endo&#39;s Chief Executive Officer Blaise Coleman said in a statement.</p><p>The company&#39;s Chapter 11 bankruptcy filing in the Southern District of New York showed assets and liabilities in the range of $1 billion to $10 billion.</p><p>The creditors, who will also assume some of the company&#39;s liabilities, will substantially control all of its assets, Endo said.</p><p>The company also reached a deal with U.S. state attorneys general to provide $450 million over a period of 10 years, resolving allegations that the company boosted opioid sales using deceptive marketing, and bans the marketing of its opioids forever, according to the office of Massachusetts AG.</p><p>Creditors will also establish voluntary trusts with $550 million to be funded over 10 years to settle the opioid claims, the company said.</p><p>Endo has been discussing the possibility of filing for bankruptcy protection in several recent filings.</p><p>In June, the drugmaker missed a $38 million interest payment, amid discussions with a group of unsecured bondholders who had urged the company to avoid filing for bankruptcy.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Endo Files for Bankruptcy As U.S. Opioid Litigation Drags</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEndo Files for Bankruptcy As U.S. Opioid Litigation Drags\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-08-17 13:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Aug 16 (Reuters) - Endo International Plc filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over its alleged role in the country&#39;s opioid epidemic.</p><p>The pharmaceutical company is the latest to file for Chapter 11 to address opioid claims. Purdue Pharma, the maker of OxyContin, filed in September 2019, while Mallinckrodt Plc, a generic opioid manufacturer, recently emerged from bankruptcy.</p><p>&#34;By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the company has been defending at an unsustainable cost, we will be able to move forward...,&#34; Endo&#39;s Chief Executive Officer Blaise Coleman said in a statement.</p><p>The company&#39;s Chapter 11 bankruptcy filing in the Southern District of New York showed assets and liabilities in the range of $1 billion to $10 billion.</p><p>The creditors, who will also assume some of the company&#39;s liabilities, will substantially control all of its assets, Endo said.</p><p>The company also reached a deal with U.S. state attorneys general to provide $450 million over a period of 10 years, resolving allegations that the company boosted opioid sales using deceptive marketing, and bans the marketing of its opioids forever, according to the office of Massachusetts AG.</p><p>Creditors will also establish voluntary trusts with $550 million to be funded over 10 years to settle the opioid claims, the company said.</p><p>Endo has been discussing the possibility of filing for bankruptcy protection in several recent filings.</p><p>In June, the drugmaker missed a $38 million interest payment, amid discussions with a group of unsecured bondholders who had urged the company to avoid filing for bankruptcy.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128839302","content_text":"Aug 16 (Reuters) - Endo International Plc filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over its alleged role in the country's opioid epidemic.The pharmaceutical company is the latest to file for Chapter 11 to address opioid claims. Purdue Pharma, the maker of OxyContin, filed in September 2019, while Mallinckrodt Plc, a generic opioid manufacturer, recently emerged from bankruptcy.\"By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the company has been defending at an unsustainable cost, we will be able to move forward...,\" Endo's Chief Executive Officer Blaise Coleman said in a statement.The company's Chapter 11 bankruptcy filing in the Southern District of New York showed assets and liabilities in the range of $1 billion to $10 billion.The creditors, who will also assume some of the company's liabilities, will substantially control all of its assets, Endo said.The company also reached a deal with U.S. state attorneys general to provide $450 million over a period of 10 years, resolving allegations that the company boosted opioid sales using deceptive marketing, and bans the marketing of its opioids forever, according to the office of Massachusetts AG.Creditors will also establish voluntary trusts with $550 million to be funded over 10 years to settle the opioid claims, the company said.Endo has been discussing the possibility of filing for bankruptcy protection in several recent filings.In June, the drugmaker missed a $38 million interest payment, amid discussions with a group of unsecured bondholders who had urged the company to avoid filing for bankruptcy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9047937673,"gmtCreate":1656850372392,"gmtModify":1676535903697,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/EVFM\">$Evofem Biosciences Inc.(EVFM)$</a>🚀&nbsp;","listText":"<a href=\"https://ttm.financial/S/EVFM\">$Evofem Biosciences Inc.(EVFM)$</a>🚀&nbsp;","text":"$Evofem Biosciences Inc.(EVFM)$🚀","images":[{"img":"https://community-static.tradeup.com/news/6c06c84fef1a44f828499a071b4a49e7","width":"1170","height":"1289"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9047937673","isVote":1,"tweetType":1,"viewCount":387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9041507159,"gmtCreate":1656067764871,"gmtModify":1676535762044,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"$MULN!","listText":"$MULN!","text":"$MULN!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9041507159","repostId":"1122496850","repostType":2,"repost":{"id":"1122496850","kind":"news","pubTimestamp":1656060539,"share":"https://ttm.financial/m/news/1122496850?lang=&edition=fundamental","pubTime":"2022-06-24 16:48","market":"us","language":"en","title":"Russell Rebalance May See Highest-Volume Trading Session of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1122496850","media":"seekingalpha","summary":"Friday might result in one of the heaviest trading of the year as FTSE Russell (OTCPK:LDNXF) complet","content":"<html><head></head><body><p>Friday might result in one of the heaviest trading of the year as FTSE Russell (OTCPK:LDNXF) completes the annual rebalancing of its indexes. These include market cap benchmarks like the Russell 2000 (NYSEARCA:IWM) and Russell 3000 (NYSEARCA:IWV), as well as other indexes based on investment style, such as the Russell 1000 Growth (NYSEARCA:IWF) and Russell 1000 Value (NYSEARCA:IWD). The popular products are benchmarked to nearly $12T of investor funds, spanning those managed by hedge funds and 401(k) providers to other institutional fund managers and even retail investors. The frenzy of buying and selling saw total trading volume on the day of the 2021 reconstitution top 16B shares, making it last year&#39;s busiest trading session.</p><p><i>How it works?</i>Given the volume and number of stocks involved, FTSE Russell (OTCPK:LDNXF) takes some steps ahead of time to be transparent about the movements. The process starts during &#34;Rank Day&#34; in May - which determines the market cap bands for a stock to be eligible for inclusion - and is followed up with preliminary lists in subsequent weeks, before the actual rebalancing occurs on the fourth Friday of June. Funds and institutional investors that track the various benchmarks are forced to scoop up or ditch stocks that are added or removed from the indexes, and it all takes place just moments before the market closes (some traders even seek to trade any price dislocations that could result from the readjustment).</p><p>&#34;We&#39;ve found that fully reconstituting the indexes annually, plus adding eligible [initial public offerings] quarterly and applying daily adjustments maintains the representative nature of the Russell U.S. Indexes while avoiding the unnecessary turnover that a more frequent rebalancing could cause,&#34; said Catherine Yoshimoto, director of product management for the Russell U.S. Indexes.</p><p><b>Interesting times:</b>Popular &#34;growth&#39; players in tech, like Meta, Netflix and PayPal, are set to move to the Russell 1000 Value Index (IWD), which is typically a domain reserved for companies trading at a discount to their fundamentals. That&#39;s due to the recent price drops of the stocks, which aredown 50-70%YTD. Meanwhile, the energy sector is set to see a heavier weighting in Russell growth indexes (IWF) (IWO), with the industry and related shares being one of the only to outperform in 2022. &#34;Growth managers that have not had to pay attention to energy for several years, now have to pay attention to the sector,&#34; explained Steve DeSanctis, equity strategist at Jefferies.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Russell Rebalance May See Highest-Volume Trading Session of the Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRussell Rebalance May See Highest-Volume Trading Session of the Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-24 16:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3851431-russell-rebalance-may-see-highest-volume-trading-session-of-the-year?source=content_type%3Areact%7Cfirst_level_url%3Ahome%7Csection%3Atrending_news%7Cline%3A1><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Friday might result in one of the heaviest trading of the year as FTSE Russell (OTCPK:LDNXF) completes the annual rebalancing of its indexes. These include market cap benchmarks like the Russell 2000 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3851431-russell-rebalance-may-see-highest-volume-trading-session-of-the-year?source=content_type%3Areact%7Cfirst_level_url%3Ahome%7Csection%3Atrending_news%7Cline%3A1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","IWM":"罗素2000指数ETF"},"source_url":"https://seekingalpha.com/news/3851431-russell-rebalance-may-see-highest-volume-trading-session-of-the-year?source=content_type%3Areact%7Cfirst_level_url%3Ahome%7Csection%3Atrending_news%7Cline%3A1","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1122496850","content_text":"Friday might result in one of the heaviest trading of the year as FTSE Russell (OTCPK:LDNXF) completes the annual rebalancing of its indexes. These include market cap benchmarks like the Russell 2000 (NYSEARCA:IWM) and Russell 3000 (NYSEARCA:IWV), as well as other indexes based on investment style, such as the Russell 1000 Growth (NYSEARCA:IWF) and Russell 1000 Value (NYSEARCA:IWD). The popular products are benchmarked to nearly $12T of investor funds, spanning those managed by hedge funds and 401(k) providers to other institutional fund managers and even retail investors. The frenzy of buying and selling saw total trading volume on the day of the 2021 reconstitution top 16B shares, making it last year's busiest trading session.How it works?Given the volume and number of stocks involved, FTSE Russell (OTCPK:LDNXF) takes some steps ahead of time to be transparent about the movements. The process starts during \"Rank Day\" in May - which determines the market cap bands for a stock to be eligible for inclusion - and is followed up with preliminary lists in subsequent weeks, before the actual rebalancing occurs on the fourth Friday of June. Funds and institutional investors that track the various benchmarks are forced to scoop up or ditch stocks that are added or removed from the indexes, and it all takes place just moments before the market closes (some traders even seek to trade any price dislocations that could result from the readjustment).\"We've found that fully reconstituting the indexes annually, plus adding eligible [initial public offerings] quarterly and applying daily adjustments maintains the representative nature of the Russell U.S. Indexes while avoiding the unnecessary turnover that a more frequent rebalancing could cause,\" said Catherine Yoshimoto, director of product management for the Russell U.S. Indexes.Interesting times:Popular \"growth' players in tech, like Meta, Netflix and PayPal, are set to move to the Russell 1000 Value Index (IWD), which is typically a domain reserved for companies trading at a discount to their fundamentals. That's due to the recent price drops of the stocks, which aredown 50-70%YTD. Meanwhile, the energy sector is set to see a heavier weighting in Russell growth indexes (IWF) (IWO), with the industry and related shares being one of the only to outperform in 2022. \"Growth managers that have not had to pay attention to energy for several years, now have to pay attention to the sector,\" explained Steve DeSanctis, equity strategist at Jefferies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9058967991,"gmtCreate":1654775277713,"gmtModify":1676535508778,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PRAX\">$Praxis Precision Medicines, Inc.(PRAX)$</a>Cmon!","listText":"<a href=\"https://ttm.financial/S/PRAX\">$Praxis Precision Medicines, Inc.(PRAX)$</a>Cmon!","text":"$Praxis Precision Medicines, Inc.(PRAX)$Cmon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9058967991","isVote":1,"tweetType":1,"viewCount":307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9053165063,"gmtCreate":1654500223952,"gmtModify":1676535458249,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SVRE\">$SAVERONE 2014 LTD(SVRE)$</a>Saver everyone","listText":"<a href=\"https://ttm.financial/S/SVRE\">$SAVERONE 2014 LTD(SVRE)$</a>Saver everyone","text":"$SAVERONE 2014 LTD(SVRE)$Saver everyone","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9053165063","isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9027752873,"gmtCreate":1654092514892,"gmtModify":1676535392789,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>Stupid nasdaq&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>Stupid nasdaq&nbsp;","text":"$NASDAQ(.IXIC)$Stupid nasdaq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9027752873","isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9027859989,"gmtCreate":1654010716941,"gmtModify":1676535378348,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>Suck beans","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$</a>Suck beans","text":"$NASDAQ(.IXIC)$Suck beans","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9027859989","isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9029536224,"gmtCreate":1652797103468,"gmtModify":1676535163261,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"I feel that whole Market is rigged.Prior to Biden's entry to office, take a&nbsp;look at how Tech stocks Emerged. Now Almost Every stock is undervalued. Worse of All, people do not Hold And grab profits and sell within 1-2 days","listText":"I feel that whole Market is rigged.Prior to Biden's entry to office, take a&nbsp;look at how Tech stocks Emerged. Now Almost Every stock is undervalued. Worse of All, people do not Hold And grab profits and sell within 1-2 days","text":"I feel that whole Market is rigged.Prior to Biden's entry to office, take a look at how Tech stocks Emerged. Now Almost Every stock is undervalued. Worse of All, people do not Hold And grab profits and sell within 1-2 days","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9029536224","isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9085359339,"gmtCreate":1650657430552,"gmtModify":1676534770904,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/MULN\">$Mullen Automotive(MULN)$</a>is the future","listText":"<a href=\"https://ttm.financial/S/MULN\">$Mullen Automotive(MULN)$</a>is the future","text":"$Mullen Automotive(MULN)$is the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9085359339","isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9090824150,"gmtCreate":1643154524772,"gmtModify":1676533779105,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9090824150","repostId":"2206103855","repostType":4,"repost":{"id":"2206103855","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1643151600,"share":"https://ttm.financial/m/news/2206103855?lang=&edition=fundamental","pubTime":"2022-01-26 07:00","market":"us","language":"en","title":"Wall Street Ends down as Markets Whipsaw Ahead of Fed Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2206103855","media":"Reuters","summary":"* Microsoft gains in after-hours trading after results* American Express, IBM rise on strong earning","content":"<html><head></head><body><p>* Microsoft gains in after-hours trading after results</p><p>* American Express, IBM rise on strong earnings</p><p>* Indexes down: Dow 0.19%, S&amp;P 1.22%, Nasdaq 2.28%</p><p>NEW YORK, Jan 25 (Reuters) - U.S. stocks gyrated in afternoon trading to close lower with interest rate sensitive tech stocks weighing most heavily as uncertainties surrounding an increasingly hawkish Federal Reserve and rising geopolitical tensions contributed to the market&#39;s churn.</p><p>In a pattern similar to Monday, U.S. stocks whipsawed between steep losses and modest gains. Equities ended well off session lows, where the S&amp;P 500 flirted once again with confirming a correction.</p><p>All three major U.S. stock indexes closed lower.</p><p>If the bellwether index closed 10% or more below its record high reached on Jan 3, it would have confirmed it entered a correction on that date. It ended the session 9.2% below that level.</p><p>&#34;We’re floating along this arbitrary 10% line, and investors are asking. &#39;Is it time to protect my capital by selling or is it time to buy the dip?&#39;,&#34; said Tom Martin, senior portfolio manager at GLOBALT in Atlanta. &#34;And between yesterday with downward and upward movement you have this battle between the two.&#34;</p><p>The CBOE Market Volatility index closed at its highest level since Jan. 29, 2021.</p><p>The Dow Jones Industrial Average fell 66.77 points, or 0.19%, to 34,297.73, the S&amp;P 500 lost 53.68 points, or 1.22%, to 4,356.45 and the Nasdaq Composite dropped 315.83 points, or 2.28%, to 13,539.30.</p><p>The members of the Federal Open Markets Committee (FOMC) convened on Tuesday for their two-day monetary policy meeting. Market participants on Wednesday will scrutinize the statement at the meeting&#39;s conclusion, along with Chairman Jerome Powell&#39;s subsequent Q&amp;A session, for clarity regarding the central bank&#39;s timeline for hiking key interest rates to combat inflation.</p><p>&#34;Certainly, the economic data of late shows some weakening,&#34; Martin added. &#34;You would think there might be a more dovish message from the Fed.&#34;</p><p>Geopolitical tensions are adding to investor uncertainty, with NATO putting forces on standby and the United States putting troops on heightened alert in response to a buildup of Russian forces along Ukraine border.</p><p>Those tensions prompted a rise in crude oil prices on concerns over tightening supply  , which in turn gave energy companies    a solid boost.</p><p>Energy was the top gainer among the 11 major sectors in the S&amp;P 500, with tech shares suffering the largest percentage decline.</p><p>The fourth-quarter reporting season is in full-stride, with 79 of the companies in the S&amp;P 500 having reported. Of those, 81% have delivered better-than-expected results, according to Refinitiv. But there have been notable misses, such as Netflix.</p><p>Analysts now see aggregate S&amp;P 500 earnings growth of 24.1% for the October-December period, per Refinitiv.</p><p>General Electric Co fell 6.0% after the industrial conglomerate, weighed down by global supply disruptions, reported a decline quarterly revenue.</p><p>IBM advanced 5.7% after the IT giant beat quarterly Wall Street estimates on strength in its cloud and consulting businesses.</p><p>American Express exceeded fourth-quarter profit estimates, sending the consumer credit company&#39;s stock up 8.9%, while Johnson &amp; Johnson gained 2.9% after reporting it expects a jump of as much as 46% in 2022 vaccine sales.</p><p>Shares of Microsoft climbed 3% after plunging 6% at one point in extended trading after the software maker reported its quarterly results.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 1.34-to-1 ratio; on Nasdaq, a 1.53-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted seven new 52-week highs and four new lows; the Nasdaq Composite recorded 19 new highs and 134 new lows.</p><p>Volume on U.S. exchanges was 13.13 billion shares, compared with the 11.23 billion average over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Ends down as Markets Whipsaw Ahead of Fed Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Ends down as Markets Whipsaw Ahead of Fed Meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-26 07:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* Microsoft gains in after-hours trading after results</p><p>* American Express, IBM rise on strong earnings</p><p>* Indexes down: Dow 0.19%, S&amp;P 1.22%, Nasdaq 2.28%</p><p>NEW YORK, Jan 25 (Reuters) - U.S. stocks gyrated in afternoon trading to close lower with interest rate sensitive tech stocks weighing most heavily as uncertainties surrounding an increasingly hawkish Federal Reserve and rising geopolitical tensions contributed to the market&#39;s churn.</p><p>In a pattern similar to Monday, U.S. stocks whipsawed between steep losses and modest gains. Equities ended well off session lows, where the S&amp;P 500 flirted once again with confirming a correction.</p><p>All three major U.S. stock indexes closed lower.</p><p>If the bellwether index closed 10% or more below its record high reached on Jan 3, it would have confirmed it entered a correction on that date. It ended the session 9.2% below that level.</p><p>&#34;We’re floating along this arbitrary 10% line, and investors are asking. &#39;Is it time to protect my capital by selling or is it time to buy the dip?&#39;,&#34; said Tom Martin, senior portfolio manager at GLOBALT in Atlanta. &#34;And between yesterday with downward and upward movement you have this battle between the two.&#34;</p><p>The CBOE Market Volatility index closed at its highest level since Jan. 29, 2021.</p><p>The Dow Jones Industrial Average fell 66.77 points, or 0.19%, to 34,297.73, the S&amp;P 500 lost 53.68 points, or 1.22%, to 4,356.45 and the Nasdaq Composite dropped 315.83 points, or 2.28%, to 13,539.30.</p><p>The members of the Federal Open Markets Committee (FOMC) convened on Tuesday for their two-day monetary policy meeting. Market participants on Wednesday will scrutinize the statement at the meeting&#39;s conclusion, along with Chairman Jerome Powell&#39;s subsequent Q&amp;A session, for clarity regarding the central bank&#39;s timeline for hiking key interest rates to combat inflation.</p><p>&#34;Certainly, the economic data of late shows some weakening,&#34; Martin added. &#34;You would think there might be a more dovish message from the Fed.&#34;</p><p>Geopolitical tensions are adding to investor uncertainty, with NATO putting forces on standby and the United States putting troops on heightened alert in response to a buildup of Russian forces along Ukraine border.</p><p>Those tensions prompted a rise in crude oil prices on concerns over tightening supply  , which in turn gave energy companies    a solid boost.</p><p>Energy was the top gainer among the 11 major sectors in the S&amp;P 500, with tech shares suffering the largest percentage decline.</p><p>The fourth-quarter reporting season is in full-stride, with 79 of the companies in the S&amp;P 500 having reported. Of those, 81% have delivered better-than-expected results, according to Refinitiv. But there have been notable misses, such as Netflix.</p><p>Analysts now see aggregate S&amp;P 500 earnings growth of 24.1% for the October-December period, per Refinitiv.</p><p>General Electric Co fell 6.0% after the industrial conglomerate, weighed down by global supply disruptions, reported a decline quarterly revenue.</p><p>IBM advanced 5.7% after the IT giant beat quarterly Wall Street estimates on strength in its cloud and consulting businesses.</p><p>American Express exceeded fourth-quarter profit estimates, sending the consumer credit company&#39;s stock up 8.9%, while Johnson &amp; Johnson gained 2.9% after reporting it expects a jump of as much as 46% in 2022 vaccine sales.</p><p>Shares of Microsoft climbed 3% after plunging 6% at one point in extended trading after the software maker reported its quarterly results.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 1.34-to-1 ratio; on Nasdaq, a 1.53-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted seven new 52-week highs and four new lows; the Nasdaq Composite recorded 19 new highs and 134 new lows.</p><p>Volume on U.S. exchanges was 13.13 billion shares, compared with the 11.23 billion average over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4503":"景林资产持仓","BK4134":"信息科技咨询与其它服务",".DJI":"道琼斯","BK4097":"系统软件",".SPX":"S&P 500 Index","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","BK4528":"SaaS概念","BK4516":"特朗普概念","IBM":"IBM","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","SPY":"标普500ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","FOMC":"FOMO CORP.","BK4525":"远程办公概念","MSFT":"微软","BK4535":"淡马锡持仓","BK4538":"云计算","BK4559":"巴菲特持仓","BK4077":"互动媒体与服务","BK4527":"明星科技股",".IXIC":"NASDAQ Composite","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2206103855","content_text":"* Microsoft gains in after-hours trading after results* American Express, IBM rise on strong earnings* Indexes down: Dow 0.19%, S&P 1.22%, Nasdaq 2.28%NEW YORK, Jan 25 (Reuters) - U.S. stocks gyrated in afternoon trading to close lower with interest rate sensitive tech stocks weighing most heavily as uncertainties surrounding an increasingly hawkish Federal Reserve and rising geopolitical tensions contributed to the market's churn.In a pattern similar to Monday, U.S. stocks whipsawed between steep losses and modest gains. Equities ended well off session lows, where the S&P 500 flirted once again with confirming a correction.All three major U.S. stock indexes closed lower.If the bellwether index closed 10% or more below its record high reached on Jan 3, it would have confirmed it entered a correction on that date. It ended the session 9.2% below that level.\"We’re floating along this arbitrary 10% line, and investors are asking. 'Is it time to protect my capital by selling or is it time to buy the dip?',\" said Tom Martin, senior portfolio manager at GLOBALT in Atlanta. \"And between yesterday with downward and upward movement you have this battle between the two.\"The CBOE Market Volatility index closed at its highest level since Jan. 29, 2021.The Dow Jones Industrial Average fell 66.77 points, or 0.19%, to 34,297.73, the S&P 500 lost 53.68 points, or 1.22%, to 4,356.45 and the Nasdaq Composite dropped 315.83 points, or 2.28%, to 13,539.30.The members of the Federal Open Markets Committee (FOMC) convened on Tuesday for their two-day monetary policy meeting. Market participants on Wednesday will scrutinize the statement at the meeting's conclusion, along with Chairman Jerome Powell's subsequent Q&A session, for clarity regarding the central bank's timeline for hiking key interest rates to combat inflation.\"Certainly, the economic data of late shows some weakening,\" Martin added. \"You would think there might be a more dovish message from the Fed.\"Geopolitical tensions are adding to investor uncertainty, with NATO putting forces on standby and the United States putting troops on heightened alert in response to a buildup of Russian forces along Ukraine border.Those tensions prompted a rise in crude oil prices on concerns over tightening supply  , which in turn gave energy companies    a solid boost.Energy was the top gainer among the 11 major sectors in the S&P 500, with tech shares suffering the largest percentage decline.The fourth-quarter reporting season is in full-stride, with 79 of the companies in the S&P 500 having reported. Of those, 81% have delivered better-than-expected results, according to Refinitiv. But there have been notable misses, such as Netflix.Analysts now see aggregate S&P 500 earnings growth of 24.1% for the October-December period, per Refinitiv.General Electric Co fell 6.0% after the industrial conglomerate, weighed down by global supply disruptions, reported a decline quarterly revenue.IBM advanced 5.7% after the IT giant beat quarterly Wall Street estimates on strength in its cloud and consulting businesses.American Express exceeded fourth-quarter profit estimates, sending the consumer credit company's stock up 8.9%, while Johnson & Johnson gained 2.9% after reporting it expects a jump of as much as 46% in 2022 vaccine sales.Shares of Microsoft climbed 3% after plunging 6% at one point in extended trading after the software maker reported its quarterly results.Declining issues outnumbered advancing ones on the NYSE by a 1.34-to-1 ratio; on Nasdaq, a 1.53-to-1 ratio favored decliners.The S&P 500 posted seven new 52-week highs and four new lows; the Nasdaq Composite recorded 19 new highs and 134 new lows.Volume on U.S. exchanges was 13.13 billion shares, compared with the 11.23 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002575948,"gmtCreate":1642053276278,"gmtModify":1676533676418,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002575948","repostId":"1120104014","repostType":2,"repost":{"id":"1120104014","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642052234,"share":"https://ttm.financial/m/news/1120104014?lang=&edition=fundamental","pubTime":"2022-01-13 13:37","market":"us","language":"en","title":"TSMC Announced Consolidated Revenue of NT$438.19 Billion, Gross Margin for the Fourth Quarter was 52.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120104014","media":"Tiger Newspress","summary":"TSMC today announced consolidated revenue of NT$438.19 billion, net income of NT$166.23 billion, and","content":"<html><head></head><body><p>TSMC today announced consolidated revenue of NT$438.19 billion, net income of NT$166.23 billion, and diluted earnings per share of NT$6.41 (US$1.15 per ADR unit) for the fourth quarter ended December 31, 2021.</p><p>Year-over-year, fourth quarter revenue increased 21.2% while net income and diluted EPS both increased 16.4%. Compared to third quarter 2021, fourth quarter results represented a 5.7% increase in revenue and a 6.4% increase in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</p><p>In US dollars, fourth quarter revenue was $15.74 billion, which increased 24.1% year-over-year and increased 5.8% from the previous quarter.</p><p>Gross margin for the quarter was 52.7%, operating margin was 41.7%, and net profit margin was 37.9%.</p><p>In the fourth quarter, shipments of 5-nanometer accounted for 23% of total wafer revenue; 7-nanometer accounted for 27%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 50% of total wafer revenue.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC Announced Consolidated Revenue of NT$438.19 Billion, Gross Margin for the Fourth Quarter was 52.7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC Announced Consolidated Revenue of NT$438.19 Billion, Gross Margin for the Fourth Quarter was 52.7%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-13 13:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>TSMC today announced consolidated revenue of NT$438.19 billion, net income of NT$166.23 billion, and diluted earnings per share of NT$6.41 (US$1.15 per ADR unit) for the fourth quarter ended December 31, 2021.</p><p>Year-over-year, fourth quarter revenue increased 21.2% while net income and diluted EPS both increased 16.4%. Compared to third quarter 2021, fourth quarter results represented a 5.7% increase in revenue and a 6.4% increase in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</p><p>In US dollars, fourth quarter revenue was $15.74 billion, which increased 24.1% year-over-year and increased 5.8% from the previous quarter.</p><p>Gross margin for the quarter was 52.7%, operating margin was 41.7%, and net profit margin was 37.9%.</p><p>In the fourth quarter, shipments of 5-nanometer accounted for 23% of total wafer revenue; 7-nanometer accounted for 27%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 50% of total wafer revenue.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120104014","content_text":"TSMC today announced consolidated revenue of NT$438.19 billion, net income of NT$166.23 billion, and diluted earnings per share of NT$6.41 (US$1.15 per ADR unit) for the fourth quarter ended December 31, 2021.Year-over-year, fourth quarter revenue increased 21.2% while net income and diluted EPS both increased 16.4%. Compared to third quarter 2021, fourth quarter results represented a 5.7% increase in revenue and a 6.4% increase in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.In US dollars, fourth quarter revenue was $15.74 billion, which increased 24.1% year-over-year and increased 5.8% from the previous quarter.Gross margin for the quarter was 52.7%, operating margin was 41.7%, and net profit margin was 37.9%.In the fourth quarter, shipments of 5-nanometer accounted for 23% of total wafer revenue; 7-nanometer accounted for 27%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 50% of total wafer revenue.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000135130,"gmtCreate":1639999025856,"gmtModify":1676533497877,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000135130","repostId":"2192909178","repostType":2,"repost":{"id":"2192909178","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639957864,"share":"https://ttm.financial/m/news/2192909178?lang=&edition=fundamental","pubTime":"2021-12-20 07:51","market":"us","language":"en","title":"EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192909178","media":"Reuters","summary":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech ","content":"<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 07:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192909178","content_text":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech and Pfizer for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.\nThese doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.\nThe commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.\nThese doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.\nGovernments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.\nOn Dec. 16, the European Commission had said that it has reached an agreement with Moderna to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.","news_type":1},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863016492,"gmtCreate":1632330976616,"gmtModify":1676530755486,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??","text":"$Clover Health Corp(CLOV)$??","images":[{"img":"https://static.tigerbbs.com/47e7305d55ee3423718c865071fc4788","width":"828","height":"1792"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863016492","isVote":1,"tweetType":1,"viewCount":574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":888538071,"gmtCreate":1631505801393,"gmtModify":1676530560528,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"Yo","listText":"Yo","text":"Yo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/888538071","repostId":"1164912986","repostType":4,"repost":{"id":"1164912986","kind":"news","pubTimestamp":1631503324,"share":"https://ttm.financial/m/news/1164912986?lang=&edition=fundamental","pubTime":"2021-09-13 11:22","market":"us","language":"en","title":"IPO Update: Definitive Healthcare Aims For $350 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1164912986","media":"seekingalpha","summary":"Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides da","content":"<p><b>Summary</b></p>\n<ul>\n <li>Definitive Healthcare has filed proposed terms for a $350 million IPO.</li>\n <li>The firm provides data and insights on the U.S. healthcare delivery ecosystem.</li>\n <li>DH is growing quickly, and while the IPO isn't cheap, the firm has strong prospects for growth ahead of it.</li>\n</ul>\n<p><b>Quick Take</b></p>\n<p>Definitive Healthcare (DH) has filed to raise $350 million from the sale of its Class A common stock in an IPO, according to an amendedregistration statement.</p>\n<p>The company provides commercial intelligence on the healthcare delivery ecosystem.</p>\n<p>I favor the space that DH is operating in and believe the firm has room for significant growth ahead of it.</p>\n<p>While the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth a close look.</p>\n<p><b>Company &amp; Technology</b></p>\n<p>Framingham, Massachusetts-based Definitive was founded to develop a SaaS platform to deliver data and insights into all aspects of the healthcare delivery system.</p>\n<p>Management is headed by founder, Chairman and CEO, Jason Krantz, who has been with the firm since inception and was previously CEO of Infinata, a SaaS provider of intelligence to the pharmaceutical industry.</p>\n<p>The company’s primary offerings by client use case include:</p>\n<ul>\n <li><p>Sales</p></li>\n <li><p>Marketing</p></li>\n <li><p>Clinical research &amp; product development</p></li>\n <li><p>Strategy</p></li>\n <li><p>Talent acquisition</p></li>\n <li><p>Physician network management</p></li>\n</ul>\n<p>Definitive has received at least $1.3 billion in equity investment from investors including Advent International, Spectrum Equity, DH Holdings, AIDH Management Holdings, and 22C Capital.</p>\n<p><b>Customer Acquisition</b></p>\n<p>The firm seeks customer relationships with:</p>\n<ul>\n <li><p>Life science companies</p></li>\n <li><p>Healthcare IT companies</p></li>\n <li><p>Healthcare providers</p></li>\n <li><p>Staffing firms</p></li>\n <li><p>Real estate firms</p></li>\n</ul>\n<p>The company counts over 2,600 companies as customers as of June 30, 2021, with no single customer accounting for more than 2% of its revenue.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased, as the figures below indicate:</p>\n<p><img src=\"https://static.tigerbbs.com/026b2d77e244b1f55f93aa472f21b1cf\" tg-width=\"608\" tg-height=\"302\" referrerpolicy=\"no-referrer\"></p>\n<p>The Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, fell slightly to 0.9x in the most recent reporting period, as shown in the table below:</p>\n<p><img src=\"https://static.tigerbbs.com/c9d709fbb5e028251cc9cd4336f21056\" tg-width=\"611\" tg-height=\"243\" referrerpolicy=\"no-referrer\">The Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.</p>\n<p>DH’s most recent calculation was 29% as of June 30, 2021, so the firm has some room for improvement in this regard, per the table below:</p>\n<p><img src=\"https://static.tigerbbs.com/8ddc5db6ab674c100956364525454370\" tg-width=\"610\" tg-height=\"243\" referrerpolicy=\"no-referrer\">The firm’s dollar-based net revenue retention rate for the year ended June 30, 2021 was 111%, a good result.</p>\n<p>The dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.</p>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2019 marketresearch reportby Grand View Research, the global market for healthcare analytics was an estimated $25.9 billion in 2019 and is expected to reach $46 billion by 2027.</p>\n<p>This represents a forecast CAGR of 7.5% from 2020 to 2027.</p>\n<p>The main drivers for this expected growth are continued digitization of healthcare data, technological advancements, and pressure to reduce healthcare spending through efficiencies.</p>\n<p>Also, the COVID-19 pandemic has provided a boost to these trends and will likely pull forward demand from healthcare ecosystem companies for greater information and capabilities.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li><p>Clarivate(NYSE:CLVT)</p></li>\n <li><p>IQVIA(NYSE:IQV)</p></li>\n <li><p>Symphony Health</p></li>\n <li><p>Komodo Health</p></li>\n <li><p>H1 Healthcare</p></li>\n <li><p>Marketware</p></li>\n <li><p>Trella Health</p></li>\n <li><p>Trilliant Health</p></li>\n <li><p>SG2</p></li>\n <li><p>Veeva(NYSE:VEEV)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Definitive’s recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Growing top line revenue</p></li>\n <li><p>Increasing gross profit and high gross margin</p></li>\n <li><p>Lowered operating losses and reduced negative operating margin</p></li>\n <li><p>Increasing cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/f71dd7e0d03f204839bbae185b0b4c54\" tg-width=\"609\" tg-height=\"618\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/5a22d972f93023350902eb166b3f6338\" tg-width=\"611\" tg-height=\"619\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/81392f625bdb5fcfddccf32a18235cca\" tg-width=\"610\" tg-height=\"618\" referrerpolicy=\"no-referrer\">As of June 30, 2021, Definitive had $38 million in cash and $555 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021 was $25.7 million.</p>\n<p><b>IPO Details</b></p>\n<p>DH intends to sell 15.55 million shares of Class A at a proposed midpoint price of $22.50 per share for gross proceeds of approximately $350 million, not including the sale of customary underwriter options.</p>\n<p>BlackRock and Capital World have indicated a non-binding interest to purchase shares of up to an aggregate of $80 million at the IPO price.</p>\n<p>Class A and Class B common stockholders will each have one vote, but Class B stockholders will not have economic rights.</p>\n<p>The S&amp;P 500 Index no longer admits firms with multiple classes of stock into its index.</p>\n<p>Assuming a successful IPO at the midpoint of the proposed price range, the company’s enterprise value at IPO (ex-underwriter options) would approximate $4.8 billion.</p>\n<p>Excluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 7.48%. A figure under 10% is generally considered a ‘low float’ stock which can be subject to significant price volatility.</p>\n<p>Per the firm’s most recent regulatory filing, it plans to use the net proceeds as follows:</p>\n<blockquote>\n We intend to use a portion of the net proceeds from this offering to [i] purchase 14,222,222 newly issued LLC Units (or 14,222,222 LLC Units, if the underwriters exercise their over-allotment option to purchase additional shares of Class A common stock in full) from Definitive OpCo, [ii] acquire 425,229 LLC Units from Pre-IPO LLC Members, and [iii] repurchase 908,104 shares of Class A common stock received by the Blocker Company equityholders in connection with the Mergers. The foregoing purchases of LLC Units and Class A common stock, respectively, will be at a price per unit equal to the public offering price per share of Class A common stock in this offering, less the underwriting discount. We have agreed to reimburse approximately $1.05 million in aggregate expenses incurred by our Sponsors in connection with the Reorganization Transactions. See “Organizational Structure—The Reorganization Transactions.”\n</blockquote>\n<blockquote>\n We will cause Definitive OpCo to use the proceeds from the issuance of the LLC Units to Definitive Healthcare Corp. as follows: [i] to pay fees and expenses not already paid from our total estimate of approximately $10.1 million in connection with this offering and the Reorganization Transactions; [ii] to repay $195.4 million of the outstanding borrowings under our Senior Credit Facilities and [iii] for general corporate purposes. Definitive OpCo will not receive any proceeds from the purchase of LLC Units from certain Pre-IPO LLC Members by us or from the repurchase of shares of Class A common stock by us.\n</blockquote>\n<p>Management’s presentation of the company roadshow isavailable here.</p>\n<p>Regarding outstanding legal proceedings, no matters are judged by management to have the potential for a material impact on the firm's operations or financial condition.</p>\n<p>Listed underwriters of the IPO are Goldman Sachs, J.P. Morgan, and several other investment banks.</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of the firm’s relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:</p>\n<p><img src=\"https://static.tigerbbs.com/0b571173d651609bed2288d8f2bb996b\" tg-width=\"614\" tg-height=\"706\" referrerpolicy=\"no-referrer\">As a reference, a potential public comparable would be Veeva Systems, although Veeva is a much larger company; shown below is a comparison of their primary valuation metrics:</p>\n<p><img src=\"https://static.tigerbbs.com/c402e45b255ff93386bdb1666f2f2740\" tg-width=\"610\" tg-height=\"360\" referrerpolicy=\"no-referrer\">Commentary</p>\n<p>DH seeks to go public to pay down debt and purchase underlying LLC interests.</p>\n<p>The firm’s financials show strong top line revenue growth and gross profit results, continued operating losses but reduced negative operating margin, so the firm appears to be making progress in this regard.</p>\n<p>Cash flow from operations is growing quickly and free cash flow for the twelve months ended June 30, 2021, was a solid $25.7 million.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenue has increased; its Sales and Marketing efficiency rate dropped slightly in the most recent reporting period.</p>\n<p>The company’s dollar-based net retention rate of 111% is a good performance metric that shows good product market fit and efficient sales &amp; marketing efforts.</p>\n<p>The market opportunity for providing healthcare delivery industry data to a wide variety of market participants is large and expected to grow at a moderate rate of growth over the coming years.</p>\n<p>Goldman Sachs is one of the lead underwriters and IPOs led by the firm over the last 12-month period have generated an average return of 45.1% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the company’s outlook is the increasing competitiveness in the markets in which it operates which may produce downward pressure on the firm’s pricing power over time.</p>\n<p>As for valuation, DH is within range of much larger competitor Veeva on revenue multiples, with a slight premium as DH is growing revenue at a faster rate of growth.</p>\n<p>However, on an EV/EBITDA or earnings basis, the DH IPO is far higher valued than Veeva’s current stock price.</p>\n<p>Still, I like the space that DH is operating in and believe the company has room for significant growth ahead of it.</p>\n<p>While the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth consideration.</p>\n<p>Expected IPO Pricing Date: September 14, 2021.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Update: Definitive Healthcare Aims For $350 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Update: Definitive Healthcare Aims For $350 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-13 11:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides data and insights on the U.S. healthcare delivery ecosystem.\nDH is growing quickly, and while the IPO ...</p>\n\n<a href=\"https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DH":"Definitive Healthcare Corp."},"source_url":"https://seekingalpha.com/article/4454054-ipo-update-definitive-healthcare-aims-for-350-million-ipo","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1164912986","content_text":"Summary\n\nDefinitive Healthcare has filed proposed terms for a $350 million IPO.\nThe firm provides data and insights on the U.S. healthcare delivery ecosystem.\nDH is growing quickly, and while the IPO isn't cheap, the firm has strong prospects for growth ahead of it.\n\nQuick Take\nDefinitive Healthcare (DH) has filed to raise $350 million from the sale of its Class A common stock in an IPO, according to an amendedregistration statement.\nThe company provides commercial intelligence on the healthcare delivery ecosystem.\nI favor the space that DH is operating in and believe the firm has room for significant growth ahead of it.\nWhile the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth a close look.\nCompany & Technology\nFramingham, Massachusetts-based Definitive was founded to develop a SaaS platform to deliver data and insights into all aspects of the healthcare delivery system.\nManagement is headed by founder, Chairman and CEO, Jason Krantz, who has been with the firm since inception and was previously CEO of Infinata, a SaaS provider of intelligence to the pharmaceutical industry.\nThe company’s primary offerings by client use case include:\n\nSales\nMarketing\nClinical research & product development\nStrategy\nTalent acquisition\nPhysician network management\n\nDefinitive has received at least $1.3 billion in equity investment from investors including Advent International, Spectrum Equity, DH Holdings, AIDH Management Holdings, and 22C Capital.\nCustomer Acquisition\nThe firm seeks customer relationships with:\n\nLife science companies\nHealthcare IT companies\nHealthcare providers\nStaffing firms\nReal estate firms\n\nThe company counts over 2,600 companies as customers as of June 30, 2021, with no single customer accounting for more than 2% of its revenue.\nSales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased, as the figures below indicate:\n\nThe Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, fell slightly to 0.9x in the most recent reporting period, as shown in the table below:\nThe Rule of 40 is a software industry rule of thumb that says that as long as the combined revenue growth rate and EBITDA percentage rate equal or exceed 40%, the firm is on an acceptable growth/EBITDA trajectory.\nDH’s most recent calculation was 29% as of June 30, 2021, so the firm has some room for improvement in this regard, per the table below:\nThe firm’s dollar-based net revenue retention rate for the year ended June 30, 2021 was 111%, a good result.\nThe dollar-based net revenue retention rate metric measures how much additional revenue is generated over time from each cohort of customers, so that a figure over 100% means that the company is generating more revenue from the same customer cohort over time, indicating good product/market fit and efficient sales and marketing efforts.\nMarket & Competition\nAccording to a 2019 marketresearch reportby Grand View Research, the global market for healthcare analytics was an estimated $25.9 billion in 2019 and is expected to reach $46 billion by 2027.\nThis represents a forecast CAGR of 7.5% from 2020 to 2027.\nThe main drivers for this expected growth are continued digitization of healthcare data, technological advancements, and pressure to reduce healthcare spending through efficiencies.\nAlso, the COVID-19 pandemic has provided a boost to these trends and will likely pull forward demand from healthcare ecosystem companies for greater information and capabilities.\nMajor competitive or other industry participants include:\n\nClarivate(NYSE:CLVT)\nIQVIA(NYSE:IQV)\nSymphony Health\nKomodo Health\nH1 Healthcare\nMarketware\nTrella Health\nTrilliant Health\nSG2\nVeeva(NYSE:VEEV)\nOthers\n\nFinancial Performance\nDefinitive’s recent financial results can be summarized as follows:\n\nGrowing top line revenue\nIncreasing gross profit and high gross margin\nLowered operating losses and reduced negative operating margin\nIncreasing cash flow from operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\nAs of June 30, 2021, Definitive had $38 million in cash and $555 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021 was $25.7 million.\nIPO Details\nDH intends to sell 15.55 million shares of Class A at a proposed midpoint price of $22.50 per share for gross proceeds of approximately $350 million, not including the sale of customary underwriter options.\nBlackRock and Capital World have indicated a non-binding interest to purchase shares of up to an aggregate of $80 million at the IPO price.\nClass A and Class B common stockholders will each have one vote, but Class B stockholders will not have economic rights.\nThe S&P 500 Index no longer admits firms with multiple classes of stock into its index.\nAssuming a successful IPO at the midpoint of the proposed price range, the company’s enterprise value at IPO (ex-underwriter options) would approximate $4.8 billion.\nExcluding effects of underwriter options and private placement shares or restricted stock, if any, the float to outstanding shares ratio will be approximately 7.48%. A figure under 10% is generally considered a ‘low float’ stock which can be subject to significant price volatility.\nPer the firm’s most recent regulatory filing, it plans to use the net proceeds as follows:\n\n We intend to use a portion of the net proceeds from this offering to [i] purchase 14,222,222 newly issued LLC Units (or 14,222,222 LLC Units, if the underwriters exercise their over-allotment option to purchase additional shares of Class A common stock in full) from Definitive OpCo, [ii] acquire 425,229 LLC Units from Pre-IPO LLC Members, and [iii] repurchase 908,104 shares of Class A common stock received by the Blocker Company equityholders in connection with the Mergers. The foregoing purchases of LLC Units and Class A common stock, respectively, will be at a price per unit equal to the public offering price per share of Class A common stock in this offering, less the underwriting discount. We have agreed to reimburse approximately $1.05 million in aggregate expenses incurred by our Sponsors in connection with the Reorganization Transactions. See “Organizational Structure—The Reorganization Transactions.”\n\n\n We will cause Definitive OpCo to use the proceeds from the issuance of the LLC Units to Definitive Healthcare Corp. as follows: [i] to pay fees and expenses not already paid from our total estimate of approximately $10.1 million in connection with this offering and the Reorganization Transactions; [ii] to repay $195.4 million of the outstanding borrowings under our Senior Credit Facilities and [iii] for general corporate purposes. Definitive OpCo will not receive any proceeds from the purchase of LLC Units from certain Pre-IPO LLC Members by us or from the repurchase of shares of Class A common stock by us.\n\nManagement’s presentation of the company roadshow isavailable here.\nRegarding outstanding legal proceedings, no matters are judged by management to have the potential for a material impact on the firm's operations or financial condition.\nListed underwriters of the IPO are Goldman Sachs, J.P. Morgan, and several other investment banks.\nValuation Metrics\nBelow is a table of the firm’s relevant capitalization and valuation metrics at IPO, excluding the effects of underwriter options:\nAs a reference, a potential public comparable would be Veeva Systems, although Veeva is a much larger company; shown below is a comparison of their primary valuation metrics:\nCommentary\nDH seeks to go public to pay down debt and purchase underlying LLC interests.\nThe firm’s financials show strong top line revenue growth and gross profit results, continued operating losses but reduced negative operating margin, so the firm appears to be making progress in this regard.\nCash flow from operations is growing quickly and free cash flow for the twelve months ended June 30, 2021, was a solid $25.7 million.\nSales and Marketing expenses as a percentage of total revenue have fluctuated as revenue has increased; its Sales and Marketing efficiency rate dropped slightly in the most recent reporting period.\nThe company’s dollar-based net retention rate of 111% is a good performance metric that shows good product market fit and efficient sales & marketing efforts.\nThe market opportunity for providing healthcare delivery industry data to a wide variety of market participants is large and expected to grow at a moderate rate of growth over the coming years.\nGoldman Sachs is one of the lead underwriters and IPOs led by the firm over the last 12-month period have generated an average return of 45.1% since their IPO. This is a mid-tier performance for all major underwriters during the period.\nThe primary risk to the company’s outlook is the increasing competitiveness in the markets in which it operates which may produce downward pressure on the firm’s pricing power over time.\nAs for valuation, DH is within range of much larger competitor Veeva on revenue multiples, with a slight premium as DH is growing revenue at a faster rate of growth.\nHowever, on an EV/EBITDA or earnings basis, the DH IPO is far higher valued than Veeva’s current stock price.\nStill, I like the space that DH is operating in and believe the company has room for significant growth ahead of it.\nWhile the IPO isn’t cheap, the firm’s prospects outweigh its price and the IPO is worth consideration.\nExpected IPO Pricing Date: September 14, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":524,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819466468,"gmtCreate":1630092742054,"gmtModify":1676530222385,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Below 20 is a buy ✌?","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Below 20 is a buy ✌?","text":"$Lucid Group Inc(LCID)$Below 20 is a buy ✌?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819466468","isVote":1,"tweetType":1,"viewCount":433,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837263172,"gmtCreate":1629894258796,"gmtModify":1676530164359,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>PT $95/&nbsp;$100","listText":"<a href=\"https://laohu8.com/S/BYSI\">$Beyondspring Inc(BYSI)$</a>PT $95/&nbsp;$100","text":"$Beyondspring Inc(BYSI)$PT $95/ $100","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/837263172","isVote":1,"tweetType":1,"viewCount":469,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831355541,"gmtCreate":1629291502783,"gmtModify":1676529993016,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VRPX\">$Virpax Pharmaceuticals, Inc.(VRPX)$</a>Take a chill&nbsp;pill at this stock.. just know when to run ??","listText":"<a href=\"https://laohu8.com/S/VRPX\">$Virpax Pharmaceuticals, Inc.(VRPX)$</a>Take a chill&nbsp;pill at this stock.. just know when to run ??","text":"$Virpax Pharmaceuticals, Inc.(VRPX)$Take a chill pill at this stock.. just know when to run ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/831355541","isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":185504542,"gmtCreate":1623658238486,"gmtModify":1704207970197,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>No one said it was going to be easy ???","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>No one said it was going to be easy ???","text":"$AMC Entertainment(AMC)$No one said it was going to be easy ???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":15,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/185504542","isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183697709,"gmtCreate":1623327064901,"gmtModify":1704200937061,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Those who don’t like this stock, wtf are you lurking around here for?!","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Those who don’t like this stock, wtf are you lurking around here for?!","text":"$Clover Health Corp(CLOV)$Those who don’t like this stock, wtf are you lurking around here for?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/183697709","isVote":1,"tweetType":1,"viewCount":2476,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581082207694869","authorId":"3581082207694869","name":"Trading Guru","avatar":"https://community-static.tradeup.com/news/765299bc38d48154b1dbbe7c431c8f70","crmLevel":1,"crmLevelSwitch":0,"idStr":"3581082207694869","authorIdStr":"3581082207694869"},"content":"lol why u care. ppl like to lurk ard u cant do much also","text":"lol why u care. ppl like to lurk ard u cant do much also","html":"lol why u care. ppl like to lurk ard u cant do much also"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803730113,"gmtCreate":1627462342032,"gmtModify":1703490429562,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>$50 tonight possible?","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>$50 tonight possible?","text":"$AMC Entertainment(AMC)$$50 tonight possible?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/803730113","isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807680609,"gmtCreate":1628034722201,"gmtModify":1703499859977,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Together fam ???","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Together fam ???","text":"$AMC Entertainment(AMC)$Together fam ???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/807680609","isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157030893,"gmtCreate":1625551662612,"gmtModify":1703743546964,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Cmon fam HODL???","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Cmon fam HODL???","text":"$Clover Health Corp(CLOV)$Cmon fam HODL???","images":[{"img":"https://static.tigerbbs.com/ba3c1c36a4e143697525d65d1f54c508","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":6,"repostSize":0,"link":"https://ttm.financial/post/157030893","isVote":1,"tweetType":1,"viewCount":827,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554171307804467","authorId":"3554171307804467","name":"不轻易买股票","avatar":"https://static.tigerbbs.com/9591045ed55f6fad3186a4cd347989e0","crmLevel":1,"crmLevelSwitch":0,"idStr":"3554171307804467","authorIdStr":"3554171307804467"},"content":"You don't even come down here?","text":"You don't even come down here?","html":"You don't even come down here?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":807063375,"gmtCreate":1627989347997,"gmtModify":1703499176089,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Guys be patient. Stick&nbsp;together gain together ??","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Guys be patient. Stick&nbsp;together gain together ??","text":"$Clover Health Corp(CLOV)$Guys be patient. Stick together gain together ??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/807063375","isVote":1,"tweetType":1,"viewCount":345,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168885613,"gmtCreate":1623971564132,"gmtModify":1703824839933,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>?","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>?","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$?","images":[{"img":"https://static.tigerbbs.com/6c6f9cf6f8ae905f53afad484a84ce82","width":"828","height":"614"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/168885613","isVote":1,"tweetType":1,"viewCount":566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":119420630,"gmtCreate":1622559699720,"gmtModify":1704186380150,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Stop the negativity! Wish ppl good luck! ????","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Stop the negativity! Wish ppl good luck! ????","text":"$AMC Entertainment(AMC)$Stop the negativity! Wish ppl good luck! ????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/119420630","isVote":1,"tweetType":1,"viewCount":448,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150972645,"gmtCreate":1624885314187,"gmtModify":1703846987009,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>0 shares left to borrow.. hang on tight.. tonight will be painful ???","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>0 shares left to borrow.. hang on tight.. tonight will be painful ???","text":"$Clover Health Corp(CLOV)$0 shares left to borrow.. hang on tight.. tonight will be painful ???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150972645","isVote":1,"tweetType":1,"viewCount":30,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115604851,"gmtCreate":1622981034373,"gmtModify":1704194036982,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>???&nbsp;?&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>???&nbsp;?&nbsp;","text":"$AMC Entertainment(AMC)$??? ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/115604851","isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804523584,"gmtCreate":1627965893648,"gmtModify":1703498764838,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Come closer ??","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Come closer ??","text":"$Clover Health Corp(CLOV)$Come closer ??","images":[{"img":"https://static.tigerbbs.com/1fa45b5eac13c600f8add0083daf9752","width":"828","height":"1590"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/804523584","isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156004559,"gmtCreate":1625184729071,"gmtModify":1703737796702,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>???","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>???","text":"$Clover Health Corp(CLOV)$???","images":[{"img":"https://static.tigerbbs.com/feee3071baa0c95a816e88c5d573ac70","width":"828","height":"1590"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/156004559","isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577345324058629","authorId":"3577345324058629","name":"埃及妖后","avatar":"https://static.tigerbbs.com/6cdcb0ed51686b3b151c75086b3f68a4","crmLevel":1,"crmLevelSwitch":0,"idStr":"3577345324058629","authorIdStr":"3577345324058629"},"content":"Will u Cost averaging","text":"Will u Cost averaging","html":"Will u Cost averaging"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":189610762,"gmtCreate":1623255197656,"gmtModify":1704199571205,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??? Diamonds are made under pressure. remember that!","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??? Diamonds are made under pressure. remember that!","text":"$Clover Health Corp(CLOV)$??? Diamonds are made under pressure. remember that!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/189610762","isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115659477,"gmtCreate":1622989441599,"gmtModify":1704194122598,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>???","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>???","text":"$AMC Entertainment(AMC)$???","images":[{"img":"https://static.tigerbbs.com/e0c34e8f918d674ba4bf3e7e9cf7d632","width":"1075","height":"806"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/115659477","isVote":1,"tweetType":1,"viewCount":428,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":804402765,"gmtCreate":1627969158557,"gmtModify":1703498829016,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Patience is a virtue ???","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Patience is a virtue ???","text":"$AMC Entertainment(AMC)$Patience is a virtue ???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/804402765","isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105233724,"gmtCreate":1620304851468,"gmtModify":1704341632368,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>???","listText":"<a href=\"https://laohu8.com/S/HOFV\">$Hall of Fame Resort &amp; Entertainment(HOFV)$</a>???","text":"$Hall of Fame Resort & Entertainment(HOFV)$???","images":[{"img":"https://static.tigerbbs.com/08bb7d67275f1992084d213f3a69bad6","width":"828","height":"1556"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/105233724","isVote":1,"tweetType":1,"viewCount":848,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":863016492,"gmtCreate":1632330976616,"gmtModify":1676530755486,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>??","text":"$Clover Health Corp(CLOV)$??","images":[{"img":"https://static.tigerbbs.com/47e7305d55ee3423718c865071fc4788","width":"828","height":"1792"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863016492","isVote":1,"tweetType":1,"viewCount":574,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":806591544,"gmtCreate":1627663734488,"gmtModify":1703494436010,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Waiting for Christmas ?&nbsp;","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Waiting for Christmas ?&nbsp;","text":"$Clover Health Corp(CLOV)$Waiting for Christmas ?","images":[{"img":"https://static.tigerbbs.com/f90d25de7360676b6b9a0dc2eeea7e1a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/806591544","isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":188398507,"gmtCreate":1623420949609,"gmtModify":1704203249953,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","listText":"<a href=\"https://laohu8.com/S/CLOV\">$Clover Health Corp(CLOV)$</a>Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","text":"$Clover Health Corp(CLOV)$Don’t listen to the naysayers! Why would they wanna come advise us? You think they care about us?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/188398507","isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3585113301120984","authorId":"3585113301120984","name":"Nictitating","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3585113301120984","authorIdStr":"3585113301120984"},"content":"Not over for CLOVer. Holding with you, friend!","text":"Not over for CLOVer. Holding with you, friend!","html":"Not over for CLOVer. Holding with you, friend!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114903005,"gmtCreate":1623039881007,"gmtModify":1704194834482,"author":{"id":"3573383772698946","authorId":"3573383772698946","name":"pravind","avatar":"https://community-static.tradeup.com/news/bac60c49a376b1cf43c4e326f986f439","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573383772698946","authorIdStr":"3573383772698946"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while.&nbsp;All the manipulation, naked shortsetc. We apes are together in this fight! ????","listText":"<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while.&nbsp;All the manipulation, naked shortsetc. We apes are together in this fight! ????","text":"$AMC Entertainment(AMC)$Everyone gotto know that this is not a fundamental play. It’s a collective effort against the unfairness done by the HF all these while. All the manipulation, naked shortsetc. We apes are together in this fight! ????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114903005","isVote":1,"tweetType":1,"viewCount":219,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}